Skip to main content

and
  1. Article

    Open Access

    Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study

    Data on adjuvant chemotherapy (CT) benefit in ER + HER2‒ early-stage breast cancer (EBC) patients with Recurrence Score (RS) 26-30 are limited. This real-world study evaluated the relationships between the RS,...

    Ofer Rotem, Idit Peretz, Michelle Leviov, Iryna Kuchuk, Amit Itay in npj Breast Cancer (2023)

  2. No Access

    Chapter

    Non-resectable Patients

    The term non-resectable (inoperable) breast cancer refers to the situation where upfront surgery will not achieve complete excision of all tumours with clear margins. These cancers can present as primary local...

    Einav Gal-Yam, Philip Poortmans in Breast Cancer Radiation Therapy (2022)